Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26920 |
Bucindolol hydrochloride
MJ 131051,Bucindolol HCl,MJ131051,MJ-13105-1,MJ-131051 |
Others | Others |
Bucindolol is a beta-adrenergic receptor antagonist. Bucindolol is a fourth-generation β-blocker. Bucindolol prevented new-onset AF; β₁ and α(2c) polymorphisms predicted therapeutic response; and the 47% of patients who were β₁389 Arg homozygotes had an e | |||
T10631 |
Bucindolol
BMY 13105,MJ 131051,MJ 13105 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Bucindolol (BMY 13105) 是一种新型有效的 β1 肾上腺素能受体 (β1-adrenergic receptor) 阻滞剂,可介导血管舒张,可用于研究慢性心力衰竭。 | |||
T10631L |
Bucindolol Formate
Bucindolol Formate (71119-11-4 Free base) |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Bucindolol Formate 是一种具有内源性拟交感活性的β1 肾上腺素能受体 (β1-adrenergic receptor) 阻滞剂。Bucindolol 可用于心力衰竭疾病研究。 |